Glaxosmithkline SA

Glaxosmithkline SA is a company in Tres Cantos Madrid, Spain that has taken part in 2 EU-funded projects since 2015, receiving €361k in EU funding.

EU funding received€361k
EU projects2
As coordinator0
Running now0
First EU project2015
Latest project2017
CountrySpain
EU registration (PIC)917933602
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Glaxosmithkline SA's own share of each project, not the project's full budget.

  • Horizon 2020€361k · 2 projects

Projects

2 EU-funded projects, newest first. Each links to the official record.

  • I-CONSENTPartner

    Improving the guidelines for Informed Consent, including vulnerable populations, under a gender perspective

    Horizon 2020 · 2017–2021 · Project on CORDIS ↗

    €361ktheir share
  • EUROLEISH-NETPartner

    Control of leishmaniasis, from bench to bedside and community

    Horizon 2020 · 2015–2018 · Project on CORDIS ↗

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • civil society
  • epidemiology
  • gender equality
  • parasitology
  • public health
  • vaccines
  • virology

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime